circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis
ABSTRACT The clinical performance of targeted therapies for treating hepatocellular carcinoma (HCC) is significantly limited by the frequent emergence of drug resistance, ultimately resulting in therapeutic failure and poor prognosis. While the precise mechanisms underlying this resistance are not f...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2025-12-01
|
| Series: | MedComm |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/mco2.70488 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|